Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy-Reference-Cited by-同舟云学术

Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy

Published:2015-10-26 Issue:2 Volume:7 Page:1242-1261
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wilfinger Nastasia¹²,Austin Shane¹²,Scheiber-Mojdehkar Barbara³,Berger Walter¹²,Reipert Siegfried⁴,Praschberger Monika³,Paur Jakob¹²,Trondl Robert⁵,Keppler Bernhard K.⁵,Zielinski Christoph C.¹²,Nowikovsky Karin¹²

Affiliation:

1. Department of Internal Medicine I, Medical University Vienna, Vienna, Austria

2. Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria

3. Department of Medical Chemistry, Medical University of Vienna, Vienna, Austria

4. Cell Imaging and Ultrastructure Research, University of Vienna, Vienna, Austria

5. Institute of Inorganic Chemistry, University of Vienna, Vienna, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased BNIP3 activity contributes to mitochondrial dysregulation: A hypothesis on the mechanism of ineffective erythropoiesis in β-thalassemia;Medical Hypotheses;2024-08

2. Therapeutic effect of trace elements on multiple myeloma and mechanisms of cancer process;Food and Chemical Toxicology;2023-09

3. To eat or not to eat mitochondria? How do host cells cope with mitophagy upon bacterial infection?;PLOS Pathogens;2023-07-06

4. Parkin exerts the tumor‐suppressive effect through targeting mitochondria;Medicinal Research Reviews;2023-03-14

5. Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects;Pharmacology & Therapeutics;2023-01